Conduit Pharmaceuticals I...

NASDAQ: CDT · Real-Time Price · USD
1.62
-0.05 (-2.99%)
At close: Aug 15, 2025, 3:59 PM
1.71
5.56%
After-hours: Aug 15, 2025, 07:24 PM EDT

Conduit Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021
Period Ending Jun 29, 2025 Mar 30, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Cash & Equivalents
301.49M 259M 554K 71K 219K 1.84M 4.23M 8.64M 277.76K 8K 345.78K 728.07K 837.69K 964.6K 48.55K
Short-Term Investments
n/a n/a 369.75M 81K 214K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a -1.33M -1.18B n/a n/a 23.34M 23.66M 136.87M 135.71M 135.1M 134.91M n/a
Other Long-Term Assets
n/a n/a 16.35M -1.46B -1.47B 1.42M 1.49M 1.57M -23.34M -23.66M -136.87M n/a 45.3K 167.22K 108.96K
Receivables
454.68M 488K 489K 734K 188K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
388.79M 373.05M 343.1M n/a 374.99M 374.42M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
77.68M 496.66M 480.67M n/a 51K 114K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
1.22B 1.13B 1.2B 1.4M 1.6M 3.16M 5.73M 10.44M 354.49K 8K 646.64K 1.15M 1.33M 1.45M 104.16K
Property-Plant & Equipment
641.81M 621.77M 614.18M 340K 369K 346K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
1.45B 1.44B 1.44B 1.46B 1.45B 1.16B n/a 5K 5K 5K 5K n/a n/a n/a n/a
Total Long-Term Assets
2.11B 2.07B 2.07B 1.6M 1.7M 1.76M 1.49M 1.57M 5K 5K 5K 135.71M 135.14M 135.07M 108.96K
Total Assets
3.33B 3.21B 4.19M 2.99M 3.31M 4.92M 7.22M 12.02M 5K 13K 5K 136.85M 136.47M 136.53M 213.13K
Account Payables
303.87M 307.06M 1.43M 1.9M 1.06M 117K 215K 35K n/a n/a n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a -144K n/a n/a 2.85M n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a 7.35M 2.41M 983K n/a 985K 981K n/a n/a 175K n/a n/a n/a 177.06K
Other Current Liabilities
615.59M 281.17M 1.96M 7.08M 638K 983K 561K 3.55M 6.36M 1.31M 1.23M 316.13K 138.65K 78.36K 15.45K
Total Current Liabilities
615.59M 588.23M 10.74M 11.98M 2.86M 1.98M 1.8M 4.6M 6.36M 3.75M 3.99M 316.13K 138.65K 78.36K 192.51K
Long-Term Debt
1.37B 1.28B n/a n/a n/a n/a n/a n/a 4.77M 4.6M 2.01M n/a n/a n/a n/a
Other Long-Term Liabilities
44.23M 8K 138K 24K 5.77M 5.86M 5.88M 5.83M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
1.48B 1.4B 1.35B 134K 5.91M 6.03M 5.88M 8.5M 9.06M 8.78M 6.09M 4.63M 4.63M 4.63M n/a
Total Liabilities
2.1B 1.98B 10.99M 12.11M 8.77M 8.02M 7.68M 13.1M 15.41M 12.53M 10.08M 4.94M 4.77M 4.71M 192.51K
Total Debt
1.37B 1.28B 7.46M 2.67M 1.27M 1.29M 985K 981K 4.77M 4.6M 2.01M n/a n/a n/a 177.06K
Common Stock
503K 503K 14K 10K 7K 7K 7K 7K 23.11M 22.86M 136.77M 135.61M 135M 134.9M 331.00
Retained Earnings
1.28B 1.23B 1.18B -26.7M -20.23M -14.85M -11.3M -13.08M -15.44M -12.93M -10.76M -3.7M -3.3M -3.08M -4.38K
Comprehensive Income
-80.58M -40.68M -3.53M 271K 387K 388K 411K 639K 29K 412K 688K n/a n/a n/a n/a
Shareholders Equity
1.23B 1.22B 1.29B -9.12M -5.46M -3.1M -457K -1.08M -15.41M -12.52M -10.08M 131.91M 131.7M 131.82M 20.62K
Total Investments
n/a n/a 369.75M 81K 214K -1.18B n/a n/a 23.34M 23.66M 136.87M 135.71M 135.1M 134.91M n/a